Global Custom Market Research Reports Provider Company


Relmada Therapeutics Inc (RLMDD) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. Its product pipeline includes REL-1017 d-Methadone, an antagonist for the treatment of neuropathic pain; REL-1028 BuTab, an oral tablet form of buprenorphine; REL-1015 LevoCap ER, an abuse resistant form of broad spectrum opioid levorphanol; and REL-1021 MepiGel, a topical gel dosage form of local anesthetic mepivacaine. Relmada Therapeutics also develops analgesics and anti-arthritic medicines. Its target treatment areas include chronic pain due to cancer, musculoskeletal disorders and peripheral neuropathy. Relmada Therapeutics is headquartered in New York, the US.

Relmada Therapeutics Inc Key Recent Developments

Jun 28,2017: Relmada Therapeutics appoints new chair of scientific advisory board
Jun 21,2017: Relmada Therapeutics appoints new executive clinical advisor
Jun 15,2017: Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
May 18,2017: Relmada Therapeutics Announces Settlement of Legal Action with Laidlaw & Company

This comprehensive SWOT profile of Relmada Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Relmada Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

Relmada Therapeutics Inc - Key Information
Relmada Therapeutics Inc - Overview
Relmada Therapeutics Inc - Key Employees
Relmada Therapeutics Inc - Key Employee Biographies
Relmada Therapeutics Inc - Key Operational Heads
Relmada Therapeutics Inc - Major Products and Services
Relmada Therapeutics Inc - History
Relmada Therapeutics Inc - Company Statement
Relmada Therapeutics Inc - Locations And Subsidiaries
Relmada Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Relmada Therapeutics Inc - Business Description
Relmada Therapeutics Inc - Corporate Strategy
Relmada Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Relmada Therapeutics Inc - Strengths
Relmada Therapeutics Inc - Weaknesses
Relmada Therapeutics Inc - Opportunities
Relmada Therapeutics Inc - Threats
Relmada Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Relmada Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Relmada Therapeutics Inc, Key Information
Relmada Therapeutics Inc, Key Ratios
Relmada Therapeutics Inc, Share Data
Relmada Therapeutics Inc, Major Products and Services
Relmada Therapeutics Inc, History
Relmada Therapeutics Inc, Key Employees
Relmada Therapeutics Inc, Key Employee Biographies
Relmada Therapeutics Inc, Key Operational Heads
Relmada Therapeutics Inc, Other Locations
Relmada Therapeutics Inc, Subsidiaries
Relmada Therapeutics Inc, Key Manufacturing facilities
Relmada Therapeutics Inc, Key Competitors
Relmada Therapeutics Inc, SWOT Analysis
Relmada Therapeutics Inc, Ratios based on current share price
Relmada Therapeutics Inc, Annual Ratios
Relmada Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Relmada Therapeutics Inc, Performance Chart
Relmada Therapeutics Inc, Ratio Charts

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system

View Report

Relmada Therapeutics Inc (Relmada Therapeutics), formerly known as Camp Nine, Inc is a clinical stage specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports